Domabio
Shanghai, China· Est.
Domabio focuses on developing novel antibody-drug conjugates (ADCs) and other targeted therapeutics for cancer treatment.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
Domabio focuses on developing novel antibody-drug conjugates (ADCs) and other targeted therapeutics for cancer treatment.
OncologyAntibodies